Department of Medicine, Division of Nephrology, Duke University and Durham Veterans Affairs Medical Centers, Durham, North Carolina, USA.
Physiol Genomics. 2010 Nov 15;42A(3):211-8. doi: 10.1152/physiolgenomics.00063.2010. Epub 2010 Aug 31.
To characterize gene expression networks linked to AT(1) angiotensin receptors in the kidney, we carried out genome-wide transcriptional analysis of RNA from kidneys of wild-type (WT) and AT(1A) receptor-deficient mice (KOs) at baseline and after 2 days of angiotensin II infusion (1,000 ng·kg(-1)·min(-1)). At baseline, 405 genes were differentially expressed (>1.5×) between WT and KO kidneys. Of these, >80% were upregulated in the KO group including genes involved in inflammation, oxidative stress, and cell proliferation. After 2 days of angiotensin II infusion in WT mice, expression of ≈805 genes was altered (18% upregulated, 82% repressed). Genes in metabolism and ion transport pathways were upregulated while there was attenuated expression of genes protective against oxidative stress including glutathione synthetase and mitochondrial superoxide dismutase 2. Angiotensin II infusion had little effect on blood pressure in KOs. Nonetheless, expression of >250 genes was altered in kidneys from KO mice during angiotensin II infusion; 14% were upregulated, while 86% were repressed including genes involved in immune responses, angiogenesis, and glutathione metabolism. Between WT and KO kidneys during angiotensin II infusion, 728 genes were differentially expressed; 10% were increased and 90% were decreased in the WT group. Differentially regulated pathways included those involved in ion transport, immune responses, metabolism, apoptosis, cell proliferation, and oxidative stress. This genome-wide assessment should facilitate identification of critical distal pathways linked to blood pressure regulation.
为了阐明与肾脏中的 AT(1)血管紧张素受体相关的基因表达网络,我们对野生型(WT)和 AT(1A)受体缺陷型(KO)小鼠(KOs)肾脏的基线和血管紧张素 II 输注(1,000 ng·kg(-1)·min(-1)) 后 2 天的 RNA 进行了全基因组转录分析。在基线时,WT 和 KO 肾脏之间有 405 个基因差异表达(>1.5×)。其中,KO 组上调的基因>80%,包括参与炎症、氧化应激和细胞增殖的基因。在 WT 小鼠接受血管紧张素 II 输注 2 天后,约 805 个基因的表达发生改变(18%上调,82%下调)。代谢和离子转运途径的基因上调,而对抗氧化应激有保护作用的基因,如谷胱甘肽合成酶和线粒体超氧化物歧化酶 2 的表达减弱。血管紧张素 II 输注对 KO 小鼠的血压几乎没有影响。尽管如此,在 KO 小鼠接受血管紧张素 II 输注期间,超过 250 个基因的表达发生改变;其中 14%上调,而 86%下调,包括参与免疫反应、血管生成和谷胱甘肽代谢的基因。在 WT 和 KO 肾脏接受血管紧张素 II 输注期间,有 728 个基因差异表达;WT 组有 10%上调,90%下调。差异调节的途径包括涉及离子转运、免疫反应、代谢、细胞凋亡、细胞增殖和氧化应激的途径。这项全基因组评估应该有助于确定与血压调节相关的关键下游途径。